Personalized Dendritic Cell Vaccines
Due to their ability to cross-present antigens associated with tumor cells to naive T cells, DCS play an important role in generating specific T-cell-mediated antitumor effector responses in controlling tumor growth and tumor cell dissemination. Clinical trials in this area have demonstrated the pos...
Autors principals: | Anzhelika Alexandrovna Melnikova, Lyudmila Yurievna Grivtsova |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Elsevier
2023-10-01
|
Col·lecció: | Hematology, Transfusion and Cell Therapy |
Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2531137923001827 |
Ítems similars
-
A STRATEGY FOR DIRECT DELIVERY OF ANTIGENIC CONSTRUCTS TO DENDRITIC CELL RECEPTORS
per: Anzhelika Melnikova, et al.
Publicat: (2024-05-01) -
Identification of Reed-Berezovsky-Sternberg cells in lymphatic nodes in classic Hodgkin's lymphoma by flow cytometry: a clinical case series
per: Firuza М. Abbasbeyli, et al.
Publicat: (2023-06-01) -
Azoximer Bromide: Mystery, Serendipity, and Promise
per: Lyudmila Yuryevna Grivtsova, et al.
Publicat: (2021-09-01) -
Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
per: Beatris Mastelic-Gavillet, et al.
Publicat: (2019-04-01) -
Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
per: Zhenyu Ding, et al.
Publicat: (2021-01-01)